BioAffinity Technologies Inc (BIAF) concluded trading on Wednesday at a closing price of $0.40, with 44.11 million shares of worth about $17.65 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -67.61% during that period and on Wednesday the price saw a gain of about 46.84%. Currently the company’s common shares owned by public are about 27.87M shares, out of which, 19.83M shares are available for trading.
Stock saw a price change of 36.94% in past 5 days and over the past one month there was a price change of -14.86%. Year-to-date (YTD), BIAF shares are showing a performance of -56.04% which decreased to -83.74% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.16 but also hit the highest price of $2.99 during that period. The average intraday trading volume for BioAffinity Technologies Inc shares is 11.82 million. The stock is currently trading 41.05% above its 20-day simple moving average (SMA20), while that difference is down -1.22% for SMA50 and it goes to -60.46% lower than SMA200.
BioAffinity Technologies Inc (NASDAQ: BIAF) currently have 27.87M outstanding shares and institutions hold larger chunk of about 1.84% of that.
The stock has a current market capitalization of $11.18M and its 3Y-monthly beta is at 2.52. It has posted earnings per share of -$0.72 in the same period. It has Quick Ratio of 0.53 while making debt-to-equity ratio of 0.92. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for BIAF, volatility over the week remained 20.20% while standing at 18.13% over the month. Stock’s fiscal year EPS is expected to rise by 46.67% while it is estimated to increase by 55.00% in next year.
